Newsroom

Categories: Omics & Genetics, Drug Discovery & Development

Lonza leads market with large and HLA-typed CD34+ cell lots for efficient humanized mouse model development

March 7, 2022

Categories: Drug Discovery & Development, Corporate, Finance & Investor, biopharma

Arctoris and Evariste Technologies form a joint venture to identify novel small molecule cMET inhibitors for non-small cell lung cancer

March 7, 2022

Categories: Biomanufacturing, Drug Discovery & Development

Germfree launches novel mobile cleanroom technology for advanced therapies

February 2, 2022

Categories: Drug Discovery & Development, Corporate, Finance & Investor

Sygnature Discovery appoints Dr Charles Woler as Chairman

January 13, 2022

Categories: Drug Discovery & Development, Corporate, Finance & Investor

Ubiquigent celebrates milestone anniversary of DUBprofiler™ compound profiling platform

December 14, 2021

Categories: Drug Discovery & Development, Clinical Research & Trials

Cytel and Pulse Infoframe deploy new real-world data solutions to transform rare disease research landscape

December 9, 2021

Categories: Drug Discovery & Development, Corporate, Finance & Investor

New CFO Jordison steps up at Sygnature Discovery

November 30, 2021

Categories: Healthcare, Drug Discovery & Development, Clinical Research & Trials

Revolutionary “sugar soap” CAVADEX reverses cholesterol blocked arteries in a matter of months

November 29, 2021

Categories: Drug Discovery & Development, Corporate, Finance & Investor

Christopher Flores, PhD appointed as President and Chief Research and Development Officer of Doloromics, Inc.

November 8, 2021